Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma

Knowledge of lncRNAs in multiple myeloma (MM) is continuously increasing.[1][1],[2][2] We and others have recently provided evidence by microarray[3][3] or RNA sequencing (RNA-seq) analyses[2][2],[4][4] that distinct lncRNA transcriptional signatures distinguished myeloma cells from their normal

• Publication year

  2018

• Venue

  Haematologica

• Publication date

  2018-09-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3324/haematol.2018.201301PMID 30213829PMCID PMC6355474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long Intergenic Non-Coding RNAs have an Independent Impact on Survival in Multiple Myeloma

  2018cited by this paper
• LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation.

  2018cited by this paper
• Long Non-Coding RNAs in Multiple Myeloma

  2018cited by this paper
• A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma

  2018cited by this paper
• NEAT1: A novel cancer‐related long non‐coding RNA

  2017cited by this paper
• Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma

  2017cited by this paper
• Paraspeckles: Where Long Noncoding RNA Meets Phase Separation.

  2017cited by this paper
• Neat1 is a p53-inducible lincRNA essential for transformation suppression

  2017cited by this paper
• Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma

  2016cited by this paper
• p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity

  2016cited by this paper
• Paraspeckle formation during the biogenesis of long non-coding RNAs

  2013cited by this paper
• Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia

  2013cited by this paper
• Alternative 3′‐end processing of long noncoding RNA initiates construction of nuclear paraspeckles

  2012cited by this paper
• Adaptive Suppression of the ATF4-CHOP Branch of the Unfolded Protein Response by Toll-Like Receptor Signaling

  2009cited by this paper
• The 8-kDa Dynein Light Chain Binds to p53-binding Protein 1 and Mediates DNA Damage-induced p53 Nuclear Accumulation*

  2005cited by this paper

• NEAT1: a multifaceted long non-coding RNA in multiple myeloma.

  2025cites this paper
• Study of the Significance of Long Noncoding RNAs: Taurine-upregulated Gene-1, Urothelial Carcinoma-associated-1, Nuclear Paraspeckle Assembly Transcript-1, and Metastasis-associated Lung Adenocarcinoma Transcript-1 in Multiple Myeloma

  2025cites this paper
• A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing.

  2024cites this paper
• Isoform balance of the long noncoding RNA NEAT1 is regulated by the RNA-binding protein QKI, governs the glioma transcriptome, and impacts cell migration

  2024cites this paper
• Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma

  2024cites this paper
• Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines

  2023cites this paper
• Transcriptional repression of lncRNA and miRNA subsets mediated by LRF during erythropoiesis

  2023cites this paper
• Identification of long noncoding RNA NEAT1 as a key gene involved in the extramedullary disease of multiple myeloma by bioinformatics analysis

  2023cites this paper
• AATF/Che‐1 localizes to paraspeckles and suppresses R‐loops accumulation and interferon activation in Multiple Myeloma

  2022cites this paper
• The Long and the Short of It: NEAT1 and Cancer Cell Metabolism

  2022cites this paper
• Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins

  2022cites this paper
• Applications of noncoding ribonucleic acids in multiple myeloma patients

  2022cites this paper
• AATF/Che-1, a new component of paraspeckles, controls R-loops formation and Interferon activation in Multiple Myeloma

  2021cites this paper
• The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma

  2021cites this paper
• Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective

  2021cites this paper
• Novel Non-coding RNA Analysis in Multiple Myeloma Identified Through High-Throughput Sequencing

  2021cites this paper
• Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma

  2021cites this paper
• Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity

  2021cites this paper
• Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma

  2021cites this paper
• The Non-Coding RNA Landscape of Plasma Cell Dyscrasias

  2020cites this paper
• Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells.

  2020cites this paper
• Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88.

  2020cites this paper
• The functional role of long noncoding RNA in resistance to anticancer treatment

  2020cites this paper
• Roles of noncoding RNAs in drug resistance in multiple myeloma

  2020cites this paper
• Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma

  2020cites this paper
• NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome

  2020cites this paper
• YY1-induced upregulation of lncRNA NEAT1 contributes to OGD/R injury-induced inflammatory response in cerebral microglial cells via Wnt/β-catenin signaling pathway

  2019cites this paper
• Elevated serum lncRNA TUG1 levels are a potential diagnostic biomarker of multiple myeloma.

  2019cites this paper
• Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer

  2019cites this paper
• Long Non-Coding RNAs in Multiple Myeloma

  2019cites this paper
• Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma

  2019influential citation
• Circulating microRNAs and Their Role in Multiple Myeloma

  2019cites this paper